Thus, addressing vascular and endothelial dysfunction could be a potential therapeutic strategy for preventing and treating MMI induced VaD and our data show that MMI significantly increases, while AV-001 treatment significantly decreases the expression of P-selectin in the CSF as well as endostatin in CSF and brain tissue. This evidence concerns the gene COL18A1 and endothelial dysfunction.